Evidence map›Paper›PMID 35273719›Full record

ReviewAmerican journal of translational research2022

Cross-linking methods of type I collagen-based scaffolds for cartilage tissue engineering.

Yu-Han Jiang, Ying-Yue Lou, Teng-Hai Li, Bing-Zhang Liu, Kang Chen, Duo Zhang, Tian Li

Abstract readReview
In one paragraph

Review in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Chemical Crosslinking of Acid Soluble Collagen Fibres.Biomimetics (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Collagen-Based Scaffolds for Meniscal Repair and Regeneration.Journal of tissue engineering and regenerative medicine · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu-Han JiangDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Ying-Yue LouDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Teng-Hai LiDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Bing-Zhang LiuDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Kang ChenDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Duo ZhangDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.
Tian LiDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Jilin University Changchun, Jilin Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cartilage defects are one of the hardest injures to cure, given the limited regenerative ability of cartilage tissues. Moreover, cartilage defects affect an increasing number of people worldwide. Therefore, scientists have attempted to develop effective strategies to repair cartilage defects in recent years. Recent advances in tissue engineering have led to the strategies for inducing cartilage regeneration. Among the emerging strategies, scaffolds are commonly used in cartilage tissue engineering (CTE) as they provide favorable environment for the growth and proliferation of chondrocytes. An ideal scaffolding material should be highly biocompatible. Type I collagen is one such material, which is widely used in CTE. However, type I collagen has poor mechanical properties and stability, which limit its use. Cross-linking is a simple method known to improve degradability, biological and mechanical properties of biomaterials by enhancing chemical and physical interactions between polymers. Cross-linking can be induced through chemical, physical or biological processes. In this review, we present cross-linking methods that can enhance the mechanical strength of type I collagen for CTE and highlight future directions in this field.

Indexed as

biomaterialscartilagecross-linkingtissue engineeringType I collagen

Identifiers

PMID35273719
PMCPMC8902548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.